Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for CASI Pharmaceuticals, Inc. (CASI)

« Back to company index

CASI Chatter Timeline

Stock Ticker for CASI

Most Active Tweeters for CASI

UserTweets
@bibeypost_stock 5
@BlogYomi 5
@bulletin_en 5
@thefinreviewer 5
@reurope_stock 3

Recent Tweets for CASI

bibeypost_stock @bibeypost_stock
Is Buying Casi Pharmaceuticals Inc $CASI, Having Higher Short Interest a Winning Strategy? https://t.co/qTpXhU5sEJ
March 21st 2019, 10:03am
mmahotstuff1 @mmahotstuff1
$-0.05 EPS Expected for CASI Pharmaceuticals, Inc. $CASI https://t.co/n4JYCWpwqz
March 21st 2019, 9:03am
whatsonthorold2 @whatsonthorold2
EPS for CASI Pharmaceuticals, Inc. $CASI Expected At $-0.05 https://t.co/6N5ypSYqWJ
March 21st 2019, 9:03am
reurope_stock @reurope_stock
EPS for CASI Pharmaceuticals, Inc. $CASI Expected At $-0.05 https://t.co/VX7Gbo9Eu9
March 21st 2019, 9:03am
UlmHi @UlmHi
Contrasting of Neurocrine Biosciences Inc. $CASI https://t.co/YSjWbOPmJP
March 20th 2019, 5:03pm
thefinreviewer @thefinreviewer
Comparison of Zymeworks Inc. $CASI https://t.co/1wZ1j8jT7e
March 20th 2019, 10:03am
bulletin_en @bulletin_en
On April, 4 Analysts See $-0.05 EPS for CASI Pharmaceuticals, Inc. $CASI https://t.co/iOor3m3Ys1
March 20th 2019, 9:03am
BlogYomi @BlogYomi
Analysts See $-0.05 EPS for CASI Pharmaceuticals, Inc. $CASI; Evolving Systems Has 1.13 Sentiment https://t.co/WL3B8Qnczr
March 20th 2019, 7:03am
thefinreviewer @thefinreviewer
Contrasting of Proteostasis Therapeutics Inc. $CASI https://t.co/ocM9CnahvR
March 20th 2019, 6:03am
thefinreviewer @thefinreviewer
Neon Therapeutics Inc. $CASI https://t.co/D6839sIASF
March 19th 2019, 9:03pm
AmericanBanking @AmericanBanking
CASI Pharmaceuticals Inc $CASI Given $11.00 Consensus Target Price by Brokerages https://t.co/ggawUQPZHD #stocks
March 19th 2019, 4:03pm
OlympiaReport @OlympiaReport
CASI Pharmaceuticals Inc $CASI Given $11.00 Average Price Target by Analysts https://t.co/j3RJKY1ZEY
March 19th 2019, 4:03pm
dispatchtribune @dispatchtribune
CASI Pharmaceuticals Inc $CASI Given $11.00 Consensus Target Price by Brokerages https://t.co/5dB7MRHK92
March 19th 2019, 4:03pm
UlmHi @UlmHi
Contrasting of AC Immune SA $CASI https://t.co/9hWSiaSmUS
March 19th 2019, 12:03am
StockTexts @StockTexts
$CASI CASI Pharmaceuticals, Inc. SEC Filing: Form NT 10-K https://t.co/lUERueO1Ts
March 18th 2019, 5:03pm
reurope_stock @reurope_stock
Careside Inc $CASI Sentiment Worsened, Despite https://t.co/sZr0yGthez
March 18th 2019, 9:03am
UlmHi @UlmHi
Reviewing Cambrex Corporation $CASI's results https://t.co/DKiL13Zx33
March 17th 2019, 10:03pm
bibeypost_stock @bibeypost_stock
$-0.05 EPS Expected for CASI Pharmaceuticals, Inc. $CASI https://t.co/752xjgWTwd
March 17th 2019, 9:03am
BlogYomi @BlogYomi
Reviewing BiondVax Pharmaceuticals Ltd. $CASI's results https://t.co/hmNBMy476X
March 17th 2019, 4:03am
thefinreviewer @thefinreviewer
Dare Bioscience Inc. $CASI Comparing side by side https://t.co/y0keJavKIf
March 17th 2019, 1:03am
BlogYomi @BlogYomi
Ra Pharmaceuticals Inc. $CASI Contrasting side by side https://t.co/8KCsihlcj4
March 17th 2019, 12:03am
BlogYomi @BlogYomi
Reviewing Odonate Therapeutics Inc. $CASI's results https://t.co/On9hrTOXUN
March 16th 2019, 6:03am
whatsonthorold2 @whatsonthorold2
$-0.05 EPS Expected for CASI Pharmaceuticals, Inc. $CASI https://t.co/QPesAS7H84
March 15th 2019, 10:03am
bulletin_en @bulletin_en
Reviewing AnaptysBio Inc. $CASI's results https://t.co/0FjE7Mhjtr
March 15th 2019, 1:03am
bibeypost_stock @bibeypost_stock
Could Casi Pharmaceuticals Inc $CASI Skyrocket? The Stock Has Too Many Sellers https://t.co/Cz5A6FYZcH
March 14th 2019, 1:03pm
reurope_stock @reurope_stock
Is Casi Pharmaceuticals Inc $CASI’s Fuel Running Low? Reports Show More Sellers https://t.co/xfegkaALcd
March 14th 2019, 1:03pm
bibeypost_stock @bibeypost_stock
EPS for CASI Pharmaceuticals, Inc. $CASI Expected At $-0.05 https://t.co/iSveRKszU5
March 14th 2019, 11:03am
MaisaCorp @MaisaCorp
$CASI unveiling an exclusive distribution agreement, under which China Resources Guokang Pharmaceuticals Co., Ltd.… https://t.co/FpGUrj8onu
March 13th 2019, 4:03pm
whatsonthorold2 @whatsonthorold2
EPS for CASI Pharmaceuticals, Inc. $CASI Expected At $-0.05 https://t.co/YBzh4VALRb
March 13th 2019, 12:03pm
StockNewsNow @StockNewsNow
$CASI CASI Pharmaceuticals Announces Exclusive Distribution Partner For Melphalan Hydrochloride For Injection (EVOM… https://t.co/amb0qVno6y
March 13th 2019, 11:03am
Madeforprofit1 @Madeforprofit1
$CASI sign China distribution - news - big upside ???? https://t.co/rXzY98fR6Y
March 13th 2019, 8:03am
Madeforprofit1 @Madeforprofit1
$CASI sign China distribution - news ??? https://t.co/n7d6ocHS19
March 13th 2019, 8:03am
FonsieTrader @FonsieTrader
$CASI: CASI Pharmaceuticals Announces Exclusive Distribution Partner For Melphalan Hydrochloride For Injection (EVOMELA®) In China
March 13th 2019, 7:03am
HottestStockNow @HottestStockNow
$CASI Inks Exclusive Distribution Deal with China Resources Guokang Pharmaceuticals for Melphalan Hydrochloride For… https://t.co/gO7pTF0lF6
March 13th 2019, 7:03am
ProTradersNews @ProTradersNews
$CASI: CASI Pharmaceuticals Announces Exclusive Distribution Partner For …: https://t.co/n6LLRWkKCi
March 13th 2019, 7:03am
bibeypost_stock @bibeypost_stock
EPS for CASI Pharmaceuticals, Inc. $CASI Expected At $-0.05 https://t.co/2sJ0rGqMlD
March 12th 2019, 11:03am
thefinreviewer @thefinreviewer
Midatech Pharma Plc $CASI Contrasting side by side https://t.co/MroOYX1zWy
March 11th 2019, 11:03pm
bulletin_en @bulletin_en
Reviewing Geron Corporation $CASI's results https://t.co/yEcezH7NMj
March 11th 2019, 8:03pm
bulletin_en @bulletin_en
$-0.05 EPS Expected for CASI Pharmaceuticals, Inc. $CASI as of April, 4 https://t.co/n9mukylZMR
March 11th 2019, 11:03am
bulletin_en @bulletin_en
CASI Pharmaceuticals, Inc. $CASI Analysts See $-0.05 EPS as of April, 4 https://t.co/5j1x8l5MoP
March 10th 2019, 11:03am
BlogYomi @BlogYomi
Kura Oncology Inc. $CASI Comparing side by side https://t.co/ZFpgTiPw5u
March 9th 2019, 12:03pm
DrugApprovalBio @DrugApprovalBio
RT @DrugApprovalBio: $CASI Announces China National Medical Products Administration Approval Of CTA To Conduct Registration Trial For MARQI…
March 8th 2019, 7:03pm
bibeypost_stock @bibeypost_stock
EPS for CASI Pharmaceuticals, Inc. $CASI Expected At $-0.05 https://t.co/pU5WaiMgjn
March 7th 2019, 1:03pm
reurope_stock @reurope_stock
Is Buying Casi Pharmaceuticals Inc $CASI, Having Higher Short Interest a Winning Strategy? https://t.co/2KJ7aCHq6k
March 7th 2019, 11:03am
Briefingcom @Briefingcom
$CASI: CASI Pharma: NMPA has approved the Co's CTQA allowing for a registration clinical trial to evaluate the... https://t.co/xsU0GHYSJi
March 7th 2019, 9:03am
DrugApprovalBio @DrugApprovalBio
$CASI Announces China National Medical Products Administration Approval Of CTA To Conduct Registration Trial For MA… https://t.co/Lhm1FvFHBp
March 7th 2019, 7:03am
newswelldone @newswelldone
$CASI: CASI Pharmaceuticals Announces China National Medical Products …: https://t.co/u1Ozw86p8C
March 7th 2019, 7:03am
portefeuillefun @portefeuillefun
RT @odibro: $CASI Announces China National Medical Products Administration Approval Of CTA To Conduct Registration Trial For MARQIBO® https…
March 7th 2019, 7:03am
odibro @odibro
$CASI Announces China National Medical Products Administration Approval Of CTA To Conduct Registration Trial For MA… https://t.co/BD3rzdlpMn
March 7th 2019, 7:03am
reurope_stock @reurope_stock
Analysts See $-0.05 EPS for CASI Pharmaceuticals, Inc. $CASI https://t.co/YiA9xP7fKg
March 6th 2019, 6:03pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.